ARTICLE | Company News
Octagen other research news
May 24, 1999 7:00 AM UTC
Octagen received a $100,000 Small Business Technology Transfer grant from the National Heart, Lung and Blood Institute to develop its second generation recombinant Factor VIII, which the company said ...